Glenmark Kicks Off Nation-wide Initiative at the Iconic Gateway of India to Promote Home Blood Pressure Monitoring Starting at Age 18. Glenmark Pharmaceuticals Limited (Glenmark), a research-led, global pharmaceutical company, and a leader in cardiovascular disease management, launched the “Take Charge @18” movement at the Gateway of India.
This Hypertension Awareness initiative emphasizes the critical importance of early blood pressure monitoring beginning at age 18. The Association of Physicians of India (API) has designated the 18th of every month as “Take charge at 18 – BP Screening Day” encouraging all adults to prioritize regular blood pressure checks to protect heart health.
This collaboration represents a significant effort by Glenmark and API to enhance hypertension awareness and diagnosis. Alok Malik, President and Business Head – India Formulations, Glenmark Pharmaceuticals Limited, said, “We at Glenmark are firmly committed to creating awareness and making a meaningful impact in the fight against hypertension in India. As cases of hypertension continue to rise at an alarming rate—especially amongst the youth—it has become a matter of necessity for us to step in with measures of prevention right at the beginning.”This initiative is supported by recent data from an ICMR study, which indicates a hypertension prevalence of 35.5% among Indians aged 20 and older, with urban areas showing rates as high as 40.7%.
